Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805
about
Effects of stimulating interleukin -2/anti- interleukin -2 antibody complexes on renal cell carcinoma.Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials.Antiangiogenic tyrosine kinase inhibitors in colorectal cancer: is there a path to making them more effective?The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma.Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma.Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway.Cardiovascular disease in cancer survivors.Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma.Toxicity and response in cats with neoplasia treated with toceranib phosphate.Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.Longitudinal and dynamic measurement invariance of the FACIT-Fatigue scale: an application of the measurement model of derivatives to ECOG-ACRIN study E2805.
P2860
Q35895478-7241AA20-39FB-4762-BE40-6D102E24C06CQ36932216-5B82B8AD-7E27-4785-BC9E-774B0137BC82Q38648762-904123FF-C361-4211-A215-7DE1D8ED6391Q38672966-650A25E0-DDA9-4DAB-B21E-7B916926E72BQ38769269-71F78CEC-D0E2-4FD5-884D-767442F21339Q38799848-6D65E785-09A9-4C52-94D4-132A1108C40BQ38812002-3C5655E1-B156-4B39-B3FF-A5CFD952E923Q39103481-CD3E3A26-61B5-48E0-89DF-F263EC260C39Q40336236-0FBE29CA-C360-4487-B6B2-69B026C9F3DBQ40793870-94F3C006-CAE7-498A-A629-B193902454EFQ45073137-5D07AC81-9128-490E-A5B3-0EC5041B9854Q52672703-94548E90-B569-4E42-B900-1E29CE6F08BF
P2860
Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Effects of Adjuvant Sorafenib ...... Results from ASSURE, ECOG 2805
@ast
Effects of Adjuvant Sorafenib ...... Results from ASSURE, ECOG 2805
@en
type
label
Effects of Adjuvant Sorafenib ...... Results from ASSURE, ECOG 2805
@ast
Effects of Adjuvant Sorafenib ...... Results from ASSURE, ECOG 2805
@en
prefLabel
Effects of Adjuvant Sorafenib ...... Results from ASSURE, ECOG 2805
@ast
Effects of Adjuvant Sorafenib ...... Results from ASSURE, ECOG 2805
@en
P2093
P2860
P1476
Effects of Adjuvant Sorafenib ...... Results from ASSURE, ECOG 2805
@en
P2093
Christopher G Wood
Christopher J Kane
Janice J Dutcher
Judith Manola
Michael B Atkins
Michael Jewett
Naomi B Haas
Robert G Uzzo
P2860
P304
P356
10.1158/1078-0432.CCR-15-0215
P407
P577
2015-05-12T00:00:00Z